UNSPSC 51283923: Sulfametrole

This classification denotes a sulfonamide anti-infective agent with the molecular formula C9H10N4O3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F5AK41IPQG, chemically known as 4-amino-n-(5-methoxy-2,1,3-thiadiazol-4-yl)benzolsulfonamid but generally known as sulfametrole, which bears US NIH Compound Identifier 64939. European Medicines Agency schedules Sulfametrole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10715MIG.

UNSPSC 51283923 Sulfametrole is a Commodity code, but the recent state and local opportunities posted under it do not align with sulfametrole procurement. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, while Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems. Neither opportunity involves sulfametrole or antimicrobial agents in the sulfametrole family. The code shows little relevant recent activity aligned with its nominal scope.

The Illinois opportunity, posted August 28, 2026 with response due September 11, 2026, represents a completed award valued at $2,999,999.11 over 12 months plus two renewal options, procured through an IFB under a cooperative purchasing vehicle. The Seminole County opportunity, posted June 30, 2026, sought annual volumes of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems through an IFB with quarterly deliveries to a county health facility; the response deadline listed in the source (July 26, 2023) appears inconsistent with the posting date. Neither procurement demonstrates state or local demand for sulfametrole itself, and the code's activity signals warrant verification against current commodity databases before pursuit.